Electronic copies of the final prospectus relating to this offering, when available, may be obtained from Maxim Group LLC, 405 Lexington Avenue, 2nd Floor, New York, NY 10174, at (212) 895-3745.

A final prospectus relating to the offering was filed with the SEC and is available on the SEC’s website at. 333-239782), as amended, previously filed with and subsequently declared effective by the Securities and Exchange Commission (“SEC”), and on Form S-1MEF (File No.

The offering was conducted pursuant to the Company’s registration statements on Form S-1 (File No. Fox Rothschild LLP acted as counsel to BIO-key in the offering. Maxim Group LLC acted as sole book-running manager for the offering. The warrants are immediately exercisable at a price of $0.65 per share and expire five years from the date of issuance. Gross proceeds before deducting underwriting discounts, commissions and other offering expenses were approximately $24.8 million.Įach share of common stock or pre-funded warrant was sold together with one common warrant to purchase one share of common stock at a combined price of $0.65. (NASDAQ: BKYI), an innovative provider of identity, security and access management solutions with biometric expertise, announced today the completion of an underwritten public offering of 38,214,500 shares of its common stock (or pre-funded warrants to purchase common stock in lieu thereof) and warrants to purchase up to an aggregate of 38,214,500 shares of its common stock, inclusive of the full exercise of the underwriters’ overallotment option. WALL, N.J., J(GLOBE NEWSWIRE) - BIO-key International, Inc.

Key to Love by Judy Ann Davis